Proxy Votes Now

Home › Funds › Virtus › Virtus KAR Health Sciences Fund

Virtus KAR Health Sciences Fund (HLHIX) proxy voting record 2025-2026

Fund family: Virtus · Filed by Virtus Investment Trust (CIK 867297) · SEC series S000007977

Share classes and tickers: HLHIX (C000150255), RAGHX (C000021683)

“With management” counts the items where the fund’s own filing gives management’s recommendation (FOR or AGAINST): 268 with, 11 against, 0 abstentions (not counted as with management). Shareholder proposals: 5 FOR, 6 AGAINST, 0 abstained, by the filing’s own vote-source field.

Compared with Virtus as a whole

The same two figures as Virtus’s manager page (46,367 ballot items across 77 funds and accounts), counted the same way for this fund.

2025-2026This fundItemsVirtusItems
Voted FOR the board's own proposals (directors, pay, auditor, capital, transactions, fund matters)98.1%26293.4%39,201
Backed environmental and social shareholder proposals at US companiesn/a48.6%1,030

Where this fund voted differently from most Virtus funds

Each ballot item this fund voted is set against the votes of the other Virtus funds and accounts on the same item (same meeting, same proposal): “most funds” is a strict majority of at least three of them, FOR against AGAINST, WITHHOLD or ABSTAIN, with split votes and items not voted left out. Funds in one family can follow separate voting policies, for example ESG funds, sub-advised funds and funds using pass-through voting.

Voted the same way as most Virtus funds on all 201 items where a comparison was possible.

Votes against management by sector

The same votes as “with management” above, by the sector of the company voted on. 95.3% of this fund’s 279 such votes could be given a sector; the other 13 (4.7%) are at companies without one and are not in the table.

SectorVotesAgainst managementShare
Health Care214115.1%
Industrials3800.0%
Consumer Discretionary1400.0%

What it voted on

Ballot items by the category the filing put first; “against management” as above.
Proposal typeItemsAgainst management
Director Elections2060
Audit-related260
Say-on-Pay240
Corporate Governance117
Compensation50
Capital Structure20
Environment or Climate22
Other Social Issues22
Shareholder Rights and Defenses20

Its largest holdings’ meetings

Position = shares voted × a recent share price, for US-listed shares of companies with a page on this site; an estimate for ranking only.

CompanyMeetingEst. positionItemsAgainst mgmt
Eli Lilly and CompanyMay 4, 2026$38M102
McKesson CorporationJuly 30, 2025$19M140
West Pharmaceutical Services, Inc.May 4, 2026$13M141
AbbVie Inc.May 8, 2026$12M81
Vertex Pharmaceuticals IncorporatedMay 13, 2026$11M141
Merck & Co., Inc.May 26, 2026$11M183
Mettler-Toledo International Inc.May 7, 2026$10M110
Thermo Fisher Scientific Inc.May 20, 2026$10M130

Notable votes against management

MeetingCompanyProposalFundMgmt
May 4, 2026Eli Lilly and CompanyShareholder proposal to adopt a policy and amend the bylaws to require an independent board chair. Shareholder proposalForAgainst
May 4, 2026Eli Lilly and CompanyShareholder proposal to prepare an annual lobbying report. Shareholder proposalAgainstFor
May 4, 2026West Pharmaceutical Services, Inc.Shareholder proposal regarding an independent Board Chair policy. Shareholder proposalForAgainst
May 8, 2026AbbVie Inc.Stockholder Proposal - to Adopt a Policy to Require an Independent Chair Shareholder proposalForAgainst
May 13, 2026Vertex Pharmaceuticals IncorporatedShareholder proposal, if properly presented at the meeting, regarding shareholder right to act by written consent. Shareholder proposalForAgainst
May 26, 2026Merck & Co., Inc.Shareholder proposal regarding a report on DEI risks in federal contracting. Shareholder proposalAgainstFor
May 26, 2026Merck & Co., Inc.Shareholder proposal regarding a report on healthcare coverage gaps. Shareholder proposalAgainstFor
May 12, 2026IDEXX Laboratories, Inc.Shareholder Proposal to Give Shareholders the Ability to Call for a Special Shareholder Meeting (Proposal Six). Shareholder proposalForAgainst
May 19, 2026Amgen Inc.Stockholder proposal to require an independent board chairman. Shareholder proposalAgainstFor
June 1, 2026UnitedHealth Group IncorporatedIf properly presented at the 2026 Annual Meeting of Shareholders, the shareholder proposal requesting the adoption of a policy to require any Board Chair to be independent. Shareholder proposalAgainstFor

Search this fund’s votes by company

280 ballot items at 24 meetings in 2025-2026. Download all votes (CSV)

Recent notable votes

Recent votes against management’s recommendation at large companies.

About this fund’s record

In the 2025-2026 proxy season, Virtus KAR Health Sciences Fund (HLHIX) voted at 24 shareholder meetings of 24 companies, on 280 ballot items in all. Where management made a recommendation, the fund followed it on 96.1% of the items and voted against it 11 times. Its most frequent area of disagreement was corporate governance (7 of its votes against management). It voted on 11 shareholder proposals. It voted FOR the board's own proposals more often than Virtus's funds as a whole (98.1% against 93.4%). It voted the same way as most Virtus funds on every item where a comparison was possible.

About this page

Every figure is derived from the fund’s own Form N-PX filings with the SEC, read item by item: one ballot item is the fund’s vote on one proposal at one meeting, and an item filed twice in the season is counted once. Percentages count items, never shares. A season is published only with at least 250 ballot items at 15 meetings. Built November 18, 2026; the family figures are those of Virtus’s manager page. The interactive database shows the same votes company by company, with every other fund that voted.